PCC Rokita SA
WSE:PCR
Intrinsic Value
PCC Rokita SA engages in the sale and production of chemical products. [ Read More ]
The intrinsic value of one PCR stock under the Base Case scenario is 88.62 PLN. Compared to the current market price of 94.4 PLN, PCC Rokita SA is Overvalued by 6%.
Valuation Backtest
PCC Rokita SA
Run backtest to discover the historical profit from buying and selling PCR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
PCC Rokita SA
Current Assets | 797.2m |
Cash & Short-Term Investments | 290m |
Receivables | 324.6m |
Other Current Assets | 182.5m |
Non-Current Assets | 1.7B |
PP&E | 1.5B |
Intangibles | 112.9m |
Other Non-Current Assets | 65.5m |
Current Liabilities | 502.2m |
Accounts Payable | 191.3m |
Accrued Liabilities | 63.9m |
Short-Term Debt | 8.1m |
Other Current Liabilities | 238.9m |
Non-Current Liabilities | 641.4m |
Long-Term Debt | 492.8m |
Other Non-Current Liabilities | 148.6m |
Earnings Waterfall
PCC Rokita SA
Revenue
|
2.4B
PLN
|
Cost of Revenue
|
-1.8B
PLN
|
Gross Profit
|
584.3m
PLN
|
Operating Expenses
|
-227.6m
PLN
|
Operating Income
|
356.7m
PLN
|
Other Expenses
|
-88.9m
PLN
|
Net Income
|
267.8m
PLN
|
Free Cash Flow Analysis
PCC Rokita SA
PCR Profitability Score
Profitability Due Diligence
PCC Rokita SA's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
PCC Rokita SA's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
PCR Solvency Score
Solvency Due Diligence
PCC Rokita SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
PCC Rokita SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PCR Price Targets Summary
PCC Rokita SA
According to Wall Street analysts, the average 1-year price target for PCR is 102.82 PLN with a low forecast of 101.81 PLN and a high forecast of 105.84 PLN.
Shareholder Return
PCR Price
PCC Rokita SA
Average Annual Return | 20.69% |
Standard Deviation of Annual Returns | 49.44% |
Max Drawdown | -62% |
Market Capitalization | 1.9B PLN |
Shares Outstanding | 19 853 300 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PCC Rokita SA engages in the sale and production of chemical products. The company is headquartered in Brzeg Dolny, Woj. Dolnoslaskie and currently employs 1,791 full-time employees. The company went IPO on 2014-06-25. The company divides its business into three segments: Chemicals that includes manufacture of such products as polyols, comprising polyether polyols for the production of polyurethane polymers, among others; chloralkali, including chlorine and soda lye; chlorobenzene, such as monochlorobenzene, dichlorobenzene and technical hydrochloric acid; phosphorus derivates; and naphthalene derivates; Energy engaged in the production and distribution of electric and thermal energy, demineralized water and compressed air; and Other Activities composed of assembly and maintenance of industrial armature, technical monitoring and consulting services, waste management, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one PCR stock under the Base Case scenario is 88.62 PLN.
Compared to the current market price of 94.4 PLN, PCC Rokita SA is Overvalued by 6%.